Related Experiment Videos

Anti-inflammatory therapeutics for the treatment of atherosclerosis

Israel F Charo1, Rebecca Taub

  • 1Gladstone Institute of Cardiovascular Disease, 1650 Owens Street #149, San Francisco, California 94158, USA. icharo@gladstone.ucsf.edu

Nature Reviews. Drug Discovery
|May 3, 2011
PubMed

Insights

Inflammation plays a key role in atherosclerosis, the main cause of heart disease and stroke. Current treatments targeting lipids don't fully address vascular inflammation, highlighting a need for new therapeutic strategies.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pharmacology

Background:

  • Atherosclerosis is a leading cause of mortality globally, primarily causing heart disease and stroke.
  • While lipid-lowering therapies reduce risk, they do not adequately address the significant role of inflammation in disease development.
  • Existing treatments for cardiovascular disease often overlook the inflammatory component of atherogenesis.

Purpose of the Study:

  • To review the evidence linking inflammation to the pathogenesis of atherosclerosis.
  • To discuss current therapeutic agents targeting vascular inflammation.
  • To outline challenges in developing novel anti-inflammatory drugs for cardiovascular disease.

Main Methods:

  • Literature review of studies on inflammation and atherosclerosis.
  • Analysis of clinical data for existing anti-inflammatory agents.
  • Perspective on drug development hurdles in targeting vascular inflammation.

Main Results:

  • Strong evidence supports inflammation's critical role in atherosclerosis development and progression.
  • Several agents targeting inflammation are in clinical use, but their efficacy in cardiovascular outcomes requires further investigation.
  • Significant challenges exist in developing drugs that specifically and safely target vascular inflammation.

Conclusions:

  • Inflammation is a crucial factor in atherosclerosis, necessitating targeted therapeutic approaches.
  • Developing effective drugs for vascular inflammation remains a key challenge in cardiovascular disease treatment.
  • Future research should focus on novel strategies to combat the inflammatory aspects of atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...